Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab

  • Etude concernée: IFCT-1603
  • Auteurs / Authors: Herbreteau G, Langlais A, Greillier L, Audigier-Valette C, Uwer L, Hureaux J, Moro-Sibilot D, Guisier F, Carmier D, Madelaine J, Otto J, Souquet PJ, Gounant V, Merle P, Molinier O, Renault A, Rabeau A, Morin F, Denis MG, Pujol JL
  • Journal / Conference: Journal of Clinical Medicine
  • Année / Year: 2020
  • PMID: 33261056
  • Lien vers la publication: https://pubmed.ncbi.nlm.nih.gov/33261056/